Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)

SHE:002252 Revenue

Shanghai RAAS Blood Products had revenue of 1.95B CNY in the quarter ending June 30, 2025, a decrease of -11.37%. This brings the company's revenue in the last twelve months to 7.88B, down -5.28% year-over-year. In the year 2024, Shanghai RAAS Blood Products had annual revenue of 8.18B with 2.67% growth.

• Revenue (ttm): 7.88B
• Revenue Growth: -5.28%
• P/S Ratio: 5.60
• Revenue / Employee: 2.35M
• Employees: 3,350
• Market Cap: 44.12B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.18B	212.50M	2.67%
Dec 31, 2023	7.96B	1.40B	21.27%
Dec 31, 2022	6.57B	2.28B	53.16%
Dec 31, 2021	4.29B	1.53B	55.26%
Dec 31, 2020	2.76B	176.70M	6.84%